Form 4: Itron CEO Thomas Deitrich Exercises Stock Options Under Pre-Arranged Plan
Insider Transaction Report
Itron, Inc. (ITRI) President and CEO Thomas Deitrich exercised 2,496 stock options at an exercise price of $40.05 per share on June 6, 2025, as disclosed in a recent SEC Form 4 filing.
Summary
- Thomas Deitrich, President & CEO and Director of Itron, Inc. (ITRI), exercised 2,496 stock options on June 6, 2025.
- The exercise price for these options was $40.05 per share.
- This transaction was conducted under a Rule 10b5-1 Trading Plan adopted by Mr. Deitrich on March 4, 2025.
- Following the transaction, Mr. Deitrich directly beneficially owns 264,524 shares of Common Stock and indirectly owns 25,000 shares through a Trust.
- The exercised options had become fully vested on February 24, 2019, and were set to expire on February 24, 2026.
Sentiment
Score: 6
Explanation: The exercise of options by a CEO, especially under a 10b5-1 plan, is a neutral to slightly positive event, indicating the executive is taking advantage of vested rights and increasing direct ownership, without necessarily implying an immediate sale or a negative outlook.
Positives
- The exercise of options by a key executive like the President & CEO can signal continued confidence in the company's long-term prospects, as it represents an increase in direct shareholding.
- The transaction was executed under a pre-arranged Rule 10b5-1 trading plan, indicating a systematic approach to managing equity rather than a reaction to immediate market conditions.
Future Outlook
NA
Industry Context
This Form 4 filing is a routine disclosure of an insider transaction and does not provide information relevant to broader industry trends or competitive analysis.
Stakeholder Impact
- Shareholders: Provides transparency regarding executive equity holdings and transactions, which can influence investor sentiment regarding insider confidence.
Key Dates
| Date | Description |
|---|---|
| 02/24/2019 | Date when the exercised stock options became fully vested. |
| 03/04/2025 | Date when Mr. Deitrich adopted the Rule 10b5-1 Trading Plan. |
| 06/06/2025 | Date of the stock option exercise transaction. |
| 06/09/2025 | Date the Form 4 filing was signed and submitted. |
| 02/24/2026 | Expiration date of the exercised stock options. |
Keywords
Itron, ITRI, SEC Form 4, Insider Trading, Stock Options, Executive Compensation, Thomas Deitrich, Rule 10b5-1 Plan, Common Stock
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.